News
Wall Street is reacting with downgrades to Novo's earnings, but with shares trading at their lowest valuation in years, patient investors could find opportunity as the stock falls.
Stocktwits on MSN23h
Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability
Shares of Danish drugmaker Novo Nordisk (NVO) traded 8% lower on Wednesday afternoon after the company slashed its full-year ...
The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of 87 cents per share. The maker of engineered products for the aerospace and other industries posted ...
Investing.com - Shares of Biogen (NASDAQ:BIIB) rose in premarket U.S. trading on Thursday after the drugmaker posted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback